Tag: DCGI

Initiative makes govt-approved testing kits available online | India News

BENGALURU: Aimed at meeting the increasing demand for Covid-19 diagnosis, a new initiative has enabled mass-scale availability of indigenously developed, ICMR/DCGI-approved diagnostic kits for government...

Covaxin out of clinical trial mode, granted restricted emergency use authorisation | India News

NEW DELHI: The Centre on Thursday said Bharat Biotech‘s indigenously developed Covaxin is out of the “clinical trial mode” and that it has now been...

Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech’s nasal vaccine | India News

NEW DELHI: An expert panel of India’s drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vaccine...

Covid-19 vaccines 110% safe, impotency rumours complete nonsense: DCGI | India News

NEW DELHI: As India gears up for the world’s largest vaccination programme, the Drugs Controller General of India (DCGI) on Sunday quelled rumours surrounding the...

DCGI may await UK nod for AstraZeneca’s Covid shot before approving SII vaccine

New Delhi | Mumbai: India’s drug regulatory body has started reviewing the application of Serum Institute of India (SII) seeking emergency use authorisation for its...

DCGI and institutional ethics committee investigating claim of adverse event in COVID vaccine trial

NEW DELHI: The Drugs Controller General of India and the institutional ethics committee at the implementation site are investigating if the adverse event as claimed...

covaxin: Bharat biotech’s COVID-19 vaccine Covaxin gets DCGI nod for phase 3 clinical trial

New Delhi: The Drugs Controller General of India (DCGI) on Friday permitted Bharat Biotech to conduct phase 3 clinical trials of its indigenously developed COVID-19...

DCGI nod to Phase-1 human trials of ‘antisera’ with potential to treat COVID-19

The Drugs Controller General of India has given permission for conducting Phase-1 human clinical trial for an “antisera” that was developed by injecting inactivated SARS-CoV-2...

DCGI approves commercial launch of low cost Covid-19 test ‘Feluda’

New Delhi: The Drugs Controller General of India has approved the commercial launch of ‘Feluda‘, the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19...

Serum Institute gets DCGI notice over Oxford COVID-19 vaccine trial suspension by AstraZeneca abroad

NEW DELHI: The central drug regulator has issued a show-cause notice to Serum Institute of India (SII) for not informing it about pharma giant AstraZeneca...

remdesivir: Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per vial

NEW DELHI: Pharmaceutical major Mylan NV on Monday said it has received approval from Indian drugs regulator DCGI to manufacture and market its remdesivir for...